 Dalrada Corporation has announced that its Pala Diagnostics LLC joint venture with Vivera Pharmaceuticals Inc performed both reverse transcription-polymerase chain reaction RT-PCR tests and US Food and Drug Administration FDA-authorized Antigen tests throughout the three-day Boise Pride Festival and Parade in Idaho. Dalrada noted that nearly 3,000 point-of-care coronavirus COVID-19 tests were administered and processed utilizing Viveras exclusive proprietary software LabPort, with recipients receiving a text message to retrieve evidence of COVID-19 testing. 